Evaluation of Coverage Rates of 3 Pediatric Vaccines (Measles-Mumps-Rubella, Hexavalent, and Varicella) in a Southern Italian Province (2016-2022): Effect of the Pandemic and Interregional Comparisons

Emanuela Santoro; Roberta Manente; Michele Nappa; Antonio Nigro; Adele D'Anna; Francesco Catapano; Walter Longanella; Maria Costantino; Domenico Fornino; Mario Capunzo; Giovanni Boccia

doi:10.12659/MSM.951332

10 April 2026 : Clinical Research

Evaluation of Coverage Rates of 3 Pediatric Vaccines (Measles-Mumps-Rubella, Hexavalent, and Varicella) in a Southern Italian Province (2016-2022): Effect of the Pandemic and Interregional Comparisons

Emanuela Santoro

^{ABCDEF 1*}, Roberta Manente

^{EF 2}, Michele Nappa^{EF 1}, Antonio Nigro^{B 3}, Adele D'Anna^{B 3}, Francesco Catapano^{B 1}, Walter Longanella^{E 4}, Maria Costantino^{E 1,2}, Domenico Fornino^{E 4}, Mario Capunzo^{E 1,2,5}, Giovanni Boccia

^{ADE 1,5,6}

DOI: 10.12659/MSM.951332

Med Sci Monit 2026; 32:e951332

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Average number of vaccinated individuals before (2016–2019) and after (2020–2022) the COVID-19 pandemic. Vaccine types: hexavalent, MMR (measles, mumps, rubella), and varicella.

Back to the Article

Evaluation of Coverage Rates of 3 Pediatric Vaccines (Measles-Mumps-Rubella, Hexavalent, and Varicella) in a Southern Italian Province (2016-2022): Effect of the Pandemic and Interregional Comparisons

Your Privacy